Status:
UNKNOWN
A Pilot Study to Evaluate Alternative Viral Load Tests During Start of Antiretroviral Therapy
Lead Sponsor:
Luis Montaner
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
HIV-1-infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A pilot study of alternative viral load testing with samples collected in the clinic and at home compared to traditional viral load monitoring in participants engaged in HIV care. Approximately 15 par...
Detailed Description
A pilot study of alternative viral load testing with samples collected in the clinic and at home compared to traditional viral load monitoring in participants engaged in HIV care. Approximately 15 par...
Eligibility Criteria
Inclusion
- Persons living with HIV starting an ART regimen or working to suppress a previously detectable viral load ≥ 5,000 copies/mL
Exclusion
- Persons living with HIV suppressed on ART regimen.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05418790
Start Date
July 1 2022
End Date
September 1 2023
Last Update
June 14 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.